Difference between revisions of "Forodesine (Fodosine)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
||
| Line 12: | Line 12: | ||
*'''Brand name:''' Fodosine, Mundesine | *'''Brand name:''' Fodosine, Mundesine | ||
| − | [[Category: | + | [[Category:Drugs]] |
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
[[Category:Chemotherapy]] | [[Category:Chemotherapy]] | ||
Revision as of 23:21, 13 June 2018
Mechanism of action
Purine nucleoside phosphorylase (PNP) inhibitor
Preliminary data
Cutaneous T-cell lymphoma
- Dummer R, Duvic M, Scarisbrick J, Olsen EA, Rozati S, Eggmann N, Goldinger SM, Hutchinson K, Geskin L, Illidge TM, Giuliano E, Elder J, Kim YH. Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome). Ann Oncol. 2014 Sep;25(9):1807-12. Epub 2014 Jun 19. link to original article PubMed
Also known as
- Code name: BCX-1777
- Generic name: Immucillin H
- Brand name: Fodosine, Mundesine